Trials / Conditions / EGFR-mutated NSCLC
EGFR-mutated NSCLC
3 registered clinical trials studyying EGFR-mutated NSCLC — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patien NCT07363252 | Gruppo Oncologico Italiano di Ricerca Clinica | — |
| Recruiting | ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC NCT06816992 | ORIC Pharmaceuticals | Phase 1 |
| Terminated | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873 | Blueprint Medicines Corporation | Phase 1 |